These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1662201)

  • 21. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
    Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of metalloproteinases and tissue inhibitors of metalloproteinases in human osteoblast-like cells: differentiation is associated with repression of metalloproteinase biosynthesis.
    Rifas L; Fausto A; Scott MJ; Avioli LV; Welgus HG
    Endocrinology; 1994 Jan; 134(1):213-21. PubMed ID: 8275936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of human recombinant 72 kDa gelatinase and tissue inhibitor of metalloproteinase-2 (TIMP-2): characterization of complex and free enzyme.
    Fridman R; Bird RE; Hoyhtya M; Oelkuct M; Komarek D; Liang CM; Berman ML; Liotta LA; Stetler-Stevenson WG; Fuerst TR
    Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):411-6. PubMed ID: 8380993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chondrocyte cultures express matrix metalloproteinase mRNA and immunoreactive protein; stromelysin-1 and 72 kDa gelatinase are localized in extracellular matrix vesicles.
    Schmitz JP; Dean DD; Schwartz Z; Cochran DL; Grant GM; Klebe RJ; Nakaya H; Boyan BD
    J Cell Biochem; 1996 Jun; 61(3):375-91. PubMed ID: 8761942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor cell invasion inhibited by TIMP-2.
    Albini A; Melchiori A; Santi L; Liotta LA; Brown PD; Stetler-Stevenson WG
    J Natl Cancer Inst; 1991 Jun; 83(11):775-9. PubMed ID: 1645772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family.
    Stetler-Stevenson WG; Krutzsch HC; Liotta LA
    J Biol Chem; 1989 Oct; 264(29):17374-8. PubMed ID: 2793861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and characterization of human tissue inhibitor of metalloproteinase-3 and detection of three additional metalloproteinase inhibitor activities in extracellular matrix.
    Kishnani NS; Staskus PW; Yang TT; Masiarz FR; Hawkes SP
    Matrix Biol; 1995 Feb; 14(6):479-88. PubMed ID: 7795886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells.
    Morodomi T; Ogata Y; Sasaguri Y; Morimatsu M; Nagase H
    Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):603-11. PubMed ID: 1379048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher-order complex formation between the 72-kilodalton type IV collagenase and tissue inhibitor of metalloproteinases-2.
    Kleiner DE; Unsworth EJ; Krutzsch HC; Stetler-Stevenson WG
    Biochemistry; 1992 Feb; 31(6):1665-72. PubMed ID: 1310615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification of an angiogenesis inhibitor from culture medium conditioned by a human chondrosarcoma-derived chondrocytic cell line, HCS-2/8.
    Ohba Y; Goto Y; Kimura Y; Suzuki F; Hisa T; Takahashi K; Takigawa M
    Biochim Biophys Acta; 1995 Aug; 1245(1):1-8. PubMed ID: 7544625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification of a metalloproteinase inhibitor from human rheumatoid synovial fluid.
    Mercer E; Cawston TE; de Silva M; Hazleman BL
    Biochem J; 1985 Nov; 231(3):505-10. PubMed ID: 3000352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).
    Dittmann KH; Lottspeich F; Ries C; Petrides PE
    Exp Hematol; 1995 Feb; 23(2):155-60. PubMed ID: 7828672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
    Terada T; Okada Y; Nakanuma Y
    Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of the C-terminal domain of metalloproteinases to binding by tissue inhibitor of metalloproteinases. C-terminal truncated stromelysin and matrilysin exhibit equally compromised binding affinities as compared to full-length stromelysin.
    Baragi VM; Fliszar CJ; Conroy MC; Ye QZ; Shipley JM; Welgus HG
    J Biol Chem; 1994 Apr; 269(17):12692-7. PubMed ID: 8175679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preferential inhibition of 72- and 92-kDa gelatinases by tissue inhibitor of metalloproteinases-2.
    Howard EW; Bullen EC; Banda MJ
    J Biol Chem; 1991 Jul; 266(20):13070-5. PubMed ID: 1649175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epithelial and bacterial metalloproteinases and their inhibitors in H. pylori infection of human gastric cells.
    Göõz M; Göõz P; Smolka AJ
    Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G823-32. PubMed ID: 11518695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of tissue inhibitor of metalloproteinase-2 (TIMP-2)-progelatinase complex as the third metalloproteinase inhibitor peak in rheumatoid synovial fluid.
    Cawston TE; Bigg HF; Clark IM; Hazleman BL
    Ann Rheum Dis; 1993 Mar; 52(3):177-81. PubMed ID: 8484669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of TIMP-2 in human alveolar macrophages. Regulation of biosynthesis is opposite to that of metalloproteinases and TIMP-1.
    Shapiro SD; Kobayashi DK; Welgus HG
    J Biol Chem; 1992 Jul; 267(20):13890-4. PubMed ID: 1629188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy.
    Benelli R; Adatia R; Ensoli B; Stetler-Stevenson WG; Santi L; Albini A
    Oncol Res; 1994; 6(6):251-7. PubMed ID: 7532474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.